GMPS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.334600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.140200E-01
Normal-vs-Stage2
2.819400E-01
Normal-vs-Stage3
7.195800E-01
Normal-vs-Stage4
1.590980E-01
Stage1-vs-Stage2
2.899800E-01
Stage1-vs-Stage3
9.637400E-01
Stage1-vs-Stage4
2.742600E-01
Stage2-vs-Stage3
4.142000E-01
Stage2-vs-Stage4
7.671800E-01
Stage3-vs-Stage4
3.753200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.532600E-01
Normal-vs-AfricanAmerican
2.074000E-01
Normal-vs-Asian
3.121200E-01
Caucasian-vs-AfricanAmerican
9.920400E-01
Caucasian-vs-Asian
9.270200E-01
AfricanAmerican-vs-Asian
9.381200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.406000E-01
Normal-vs-Female
3.338800E-01
Male-vs-Female
8.970400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.517000E-01
Normal-vs-Age(41-60Yrs)
2.169000E-01
Normal-vs-Age(61-80Yrs)
4.036400E-01
Normal-vs-Age(81-100Yrs)
2.932400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.258200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.444420E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.467810E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.784390E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.540600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.469600E-01
Normal-vs-Daily Drinker
5.973800E-01
Normal-vs-Weekly Drinker
3.407200E-01
Normal-vs-Occasional Drinker
1.668650E-01
Normal-vs-Social Drinker
3.301200E-01
Non Drinker-vs-Daily Drinker
3.802000E-01
Non Drinker-vs-Weekly Drinker
8.917000E-01
Non Drinker-vs-Occasional Drinker
2.277400E-01
Non Drinker-vs-Social Drinker
8.183000E-01
Daily Drinker-vs-Weekly Drinker
4.602000E-01
Daily Drinker-vs-Occasional Drinker
3.394000E-02
Daily Drinker-vs-Social Drinker
2.728000E-01
Weekly Drinker-vs-Occasional Drinker
1.970360E-01
Weekly Drinker-vs-Social Drinker
7.093400E-01
Occasional Drinker-vs-Social Drinker
3.739600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.863400E-01
Normal-vs-Grade 2
5.325800E-02
Normal-vs-Grade 3
8.706000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.88116999999544E-05
Grade 1-vs-Grade 3
9.52139999954582E-07
Grade 1-vs-Grade 4
4.863400E-01
Grade 2-vs-Grade 3
3.457800E-02
Grade 2-vs-Grade 4
5.325800E-02
Grade 3-vs-Grade 4
8.706000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.374600E-01
Normal-vs-NonDiabetic
3.388200E-01
Diabetic-vs-NonDiabetic
4.501000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.558300E-02
Normal-vs-NoPancreatitis
3.786000E-01
Pancreatitis-vs-NoPancreatitis
7.823900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.986000E-01
Normal-vs-N1
3.120400E-01
N0-vs-N1
9.004600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.807700E-02
Normal-vs-TP53-NonMutant
5.970600E-01
TP53-Mutant-vs-TP53-NonMutant
1.12309999966698E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
